{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:35:55Z","timestamp":1791250555628,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000658","name":"Myotubular Trust, Great Britain","doi-asserted-by":"publisher","award":["12KCL01"],"award-info":[{"award-number":["12KCL01"]}],"id":[{"id":"10.13039\/501100000658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council NI Research","doi-asserted-by":"publisher","award":["MR\/N002768\/1"],"award-info":[{"award-number":["MR\/N002768\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A-146198"],"award-info":[{"award-number":["31003A-146198"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010776","name":"OPO Stiftung","doi-asserted-by":"publisher","award":["2013\/14-0036"],"award-info":[{"award-number":["2013\/14-0036"]}],"id":[{"id":"10.13039\/100010776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000658","name":"Myotubular Trust, Great Britain","doi-asserted-by":"publisher","award":["12KCL01"],"award-info":[{"award-number":["12KCL01"]}],"id":[{"id":"10.13039\/501100000658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000658","name":"Telethon Italy","doi-asserted-by":"publisher","award":["GGP14003"],"award-info":[{"award-number":["GGP14003"]}],"id":[{"id":"10.13039\/501100000658","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Anaesthesia Basel University Hospital"},{"DOI":"10.13039\/501100001674","name":"Leducq Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semcdb.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T16:26:19Z","timestamp":1470759979000},"page":"191-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Current and future therapeutic approaches to the congenital myopathies"],"prefix":"10.1016","volume":"64","author":[{"given":"Heinz","family":"Jungbluth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ochala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Treves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Gautel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2013","journal-title":"Neuromuscul. Disord: NMD"},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2013.01.004","article-title":"Congenital myopathies?clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom","volume":"23","author":"Maggi","year":"2013","journal-title":"Neuromuscul. Disord.: NMD"},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0015","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric united states population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2012","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-2-25","article-title":"Central core disease","volume":"2","author":"Jungbluth","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-2-31","article-title":"Multi-minicore disease","volume":"2","author":"Jungbluth","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0040","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/hmg\/ddt494","article-title":"Recessive TTN truncating mutations define novel forms of core myopathy with heart disease","volume":"23","author":"Chauveau","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.semcdb.2016.08.004_bib0045","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.nmd.2012.06.007","article-title":"Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement","volume":"22","author":"Cullup","year":"2012","journal-title":"Neuromuscul. Disord.: NMD"},{"key":"10.1016\/j.semcdb.2016.08.004_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.semcdb.2016.08.004_bib0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul. Disord.: NMD"},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00415-012-6817-7","article-title":"A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"260","author":"Loseth","year":"2013","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.semcdb.2016.08.004_bib0065","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/01.wnl.0000188870.37076.f2","article-title":"Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene","volume":"65","author":"Jungbluth","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.semcdb.2016.08.004_bib0075","doi-asserted-by":"crossref","first-page":"E1544","DOI":"10.1002\/humu.21278","article-title":"Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion","volume":"31","author":"Clarke","year":"2010","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/342719","article-title":"Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies","volume":"71","author":"Ferreiro","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng713","article-title":"Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome","volume":"29","author":"Moghadaszadeh","year":"2001","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.20077","article-title":"Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene","volume":"55","author":"Ferreiro","year":"2004","journal-title":"Ann. Neurol."},{"issue":"18","key":"10.1016\/j.semcdb.2016.08.004_bib0095","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20051282","article-title":"Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes","volume":"395","author":"Ducreux","year":"2006","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ceca.2008.10.001","article-title":"A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity","volume":"45","author":"Ghassemi","year":"2009","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yexcr.2006.10.005","article-title":"Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo","volume":"313","author":"Deniziak","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"34","key":"10.1016\/j.semcdb.2016.08.004_bib0115","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1073\/pnas.0806015105","article-title":"Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle","volume":"105","author":"Jurynec","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"43","key":"10.1016\/j.semcdb.2016.08.004_bib0120","doi-asserted-by":"crossref","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","article-title":"Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors","volume":"272","author":"Fruen","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","article-title":"Malignant hyperthermia testing in probands without adverse anesthetic reaction","volume":"123","author":"Timmins","year":"2015","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2011.12.003","article-title":"182nd ENMC International Workshop: RYR1-related myopathies, 15\u201317th April 2011, Naarden, The Netherlands","volume":"22","author":"Jungbluth","year":"2012","journal-title":"Neuromuscul. Disord.: NMD"},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1213\/00000539-199804000-00047","article-title":"Prophylactic use of dantrolene in a patient with central core disease","volume":"86","author":"Michalek-Sauberer","year":"1998","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0140","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.ddmec.2010.09.009","article-title":"Fixing ryanodine receptor Ca leak\u2014a novel therapeutic strategy for contractile failure in heart and skeletal muscle","volume":"7","author":"Andersson","year":"2010","journal-title":"Drug Discov. Today Dis. Mech."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI62834","article-title":"Calcium cycling proteins and heart failure: mechanisms and therapeutics","volume":"123","author":"Marks","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0150","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0711074105","article-title":"Remodeling of ryanodine receptor complex causes leaky channels: a molecular mechanism for decreased exercise capacity","volume":"105","author":"Bellinger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0155","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2337\/diabetes.54.4.928","article-title":"Long-term AICAR administration and exercise prevents diabetes in ZDF rats","volume":"54","author":"Pold","year":"2005","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation","volume":"18","author":"Lanner","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","article-title":"RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice","volume":"133","author":"Durham","year":"2008","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0170","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21644","article-title":"Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment","volume":"65","author":"Arbogast","year":"2009","journal-title":"Ann. Neurol."},{"issue":"Pt. 4","key":"10.1016\/j.semcdb.2016.08.004_bib0175","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/aws036","article-title":"Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy","volume":"135","author":"Dowling","year":"2012","journal-title":"Brain: J. Neurol."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0092-8674(00)00054-4","article-title":"The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions","volume":"102","author":"Eu","year":"2000","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.semcdb.2016.08.004_bib0185","doi-asserted-by":"crossref","first-page":"34514","DOI":"10.1074\/jbc.M404290200","article-title":"Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry","volume":"279","author":"Voss","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"issue":"Suppl.(3)","key":"10.1016\/j.semcdb.2016.08.004_bib0195","article-title":"Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction","volume":"33","author":"Schreuder","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6868","key":"10.1016\/j.semcdb.2016.08.004_bib0200","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.semcdb.2016.08.004_bib0205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/hum.2013.052","article-title":"Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy","volume":"24","author":"Rendu","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"10","key":"10.1016\/j.semcdb.2016.08.004_bib0210","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddg121","article-title":"A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia","volume":"12","author":"Monnier","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"10.1016\/j.semcdb.2016.08.004_bib0215","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1093\/hmg\/ddv195","article-title":"Epigenetic changes as a common trigger of muscle weakness in congenital myopathies","volume":"24","author":"Rokach","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semcdb.2016.07.017","article-title":"Ca2+ handling abnormalities in early-onset muscle diseases: novel concepts and perspective","volume":"64","author":"Treves","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"18","key":"10.1016\/j.semcdb.2016.08.004_bib0225","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1093\/emboj\/18.18.5099","article-title":"HDAC4 deacetylase associates with and represses the MEF2 transcription factor","volume":"18","author":"Miska","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.semcdb.2016.08.004_bib0240","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat. Genet."},{"issue":"Pt 12","key":"10.1016\/j.semcdb.2016.08.004_bib0245","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/brain\/awu272","article-title":"Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations","volume":"137","author":"Bohm","year":"2014","journal-title":"Brain: J. Neurol."},{"issue":"9","key":"10.1016\/j.semcdb.2016.08.004_bib0250","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng2086","article-title":"Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy","volume":"39","author":"Nicot","year":"2007","journal-title":"Nat. Genet."},{"issue":"14","key":"10.1016\/j.semcdb.2016.08.004_bib0255","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","article-title":"Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy","volume":"81","author":"Ceyhan-Birsoy","year":"2013","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.semcdb.2016.08.004_bib0260","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/hmg\/ddl250","article-title":"A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy","volume":"15","author":"Tosch","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajhg.2012.06.012","article-title":"Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores","volume":"91","author":"Majczenko","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajhg.2014.07.004","article-title":"SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy","volume":"95","author":"Agrawal","year":"2014","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nmd.2006.09.013","article-title":"MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement","volume":"17","author":"Schessl","year":"2007","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0280","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ana.21089","article-title":"C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy","volume":"61","author":"Carmignac","year":"2007","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","article-title":"Medical complications in long-term survivors with X-linked myotubular myopathy","volume":"134","author":"Herman","year":"1999","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nmd.2009.10.005","article-title":"Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation","volume":"20","author":"Jungbluth","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0295","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fnagi.2014.00339","article-title":"Pathogenic mechanisms in centronuclear myopathies","volume":"6","author":"Jungbluth","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0300","doi-asserted-by":"crossref","first-page":"e1002595","DOI":"10.1371\/journal.pgen.1002595","article-title":"Defective membrane remodeling in neuromuscular diseases: insights from animal models","volume":"8","author":"Cowling","year":"2012","journal-title":"PLoS Genet."},{"issue":"220","key":"10.1016\/j.semcdb.2016.08.004_bib0305","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007523","article-title":"Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy","volume":"6","author":"Childers","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"33","key":"10.1016\/j.semcdb.2016.08.004_bib0310","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1073\/pnas.1003677107","article-title":"MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers","volume":"107","author":"Beggs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.semcdb.2016.08.004_bib0315","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy","volume":"22","author":"Lawlor","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0320","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI71206","article-title":"Reducing dynamin 2 expression rescues X-linked centronuclear myopathy","volume":"124","author":"Cowling","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.semcdb.2016.08.004_bib0325","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMcibr1403629","article-title":"Translating the genomic revolution\u2014targeted genome editing in primates","volume":"370","author":"Cathomen","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0330","first-page":"852","article-title":"Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models","volume":"5","author":"Dowling","year":"2012","journal-title":"Dis. Models Mech."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0335","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","article-title":"Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy","volume":"91","author":"Gibbs","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0340","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","article-title":"Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies","volume":"21","author":"Robb","year":"2011","journal-title":"Neuromuscul. Disord.: NMD"},{"issue":"9","key":"10.1016\/j.semcdb.2016.08.004_bib0345","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/humu.22611","article-title":"A rising titan: TTN review and mutation update","volume":"35","author":"Chauveau","year":"2014","journal-title":"Hum. Mutat."},{"issue":"24","key":"10.1016\/j.semcdb.2016.08.004_bib0350","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1212\/WNL.0000000000002200","article-title":"A new titinopathy: childhood-juvenile onset Emery-Dreifuss-like phenotype without cardiomyopathy","volume":"85","author":"De Cid","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0355","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.semcdb.2016.08.004_bib0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","article-title":"Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial","volume":"2","author":"Kerem","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0365","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/15592294.2015.1027853","article-title":"A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies","volume":"10","author":"Agrelo","year":"2015","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0370","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jcmm.12744","article-title":"Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1(R151X) mouse model of INCL","volume":"20","author":"Thada","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0375","first-page":"1","article-title":"Ataluren for the treatment of cystic fibrosis","volume":"24","author":"Shoseyov","year":"2016","journal-title":"Expert Rev. Respir. Med."},{"issue":"7","key":"10.1016\/j.semcdb.2016.08.004_bib0380","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tig.2012.05.001","article-title":"The uncertain road towards genomic medicine","volume":"28","author":"MacArthur","year":"2012","journal-title":"Trends Genet.: TIG"},{"issue":"6235","key":"10.1016\/j.semcdb.2016.08.004_bib0385","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1261877","article-title":"Human genomics. Effect of predicted protein-truncating genetic variants on the human transcriptome","volume":"348","author":"Rivas","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0390","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI71919","article-title":"Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle","volume":"124","author":"Winter","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.semcdb.2016.08.004_bib0395","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2174\/1381612821666150105160059","article-title":"Phenylbutyric acid: simple structure\u2014multiple effects","volume":"21","author":"Kusaczuk","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.semcdb.2016.08.004_bib0400","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","article-title":"Histone deacetylase inhibition blunts ischemia\/reperfusion injury by inducing cardiomyocyte autophagy","volume":"129","author":"Xie","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.semcdb.2016.08.004_bib0405","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymeth.2015.05.017","article-title":"ESI-IMS-MS. A method for rapid analysis of protein aggregation and its inhibition by small molecules","volume":"95","author":"Young","year":"2015","journal-title":"Methods"},{"issue":"6273","key":"10.1016\/j.semcdb.2016.08.004_bib0410","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0415","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/mus.24765","article-title":"Prevalence and phenotypes of congenital myopathy due to alpha-actin 1 gene mutations","volume":"53","author":"Witting","year":"2016","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0420","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/WCO.0b013e328364d681","article-title":"Recent advances in nemaline myopathy","volume":"26","author":"Romero","year":"2013","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-012-1019-z","article-title":"Skeletal muscle alpha-actin diseases (actinopathies): pathology and mechanisms","volume":"125","author":"Nowak","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0430","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI80057","article-title":"Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy","volume":"125","author":"Yuen","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0435","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.1080","article-title":"Nemaline myopathy: a clinical study of 143 cases","volume":"50","author":"Ryan","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0440","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.ph.58.030196.002311","article-title":"Thin filament-mediated regulation of cardiac contraction","volume":"58","author":"Tobacman","year":"1996","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0445","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/physrev.2000.80.2.853","article-title":"Regulation of contraction in striated muscle","volume":"80","author":"Gordon","year":"2000","journal-title":"Physiol. Rev."},{"issue":"Pt. 12","key":"10.1016\/j.semcdb.2016.08.004_bib0450","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/brain\/awr274","article-title":"Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy","volume":"134","author":"Nguyen","year":"2011","journal-title":"Brain: J. Neurol."},{"issue":"21","key":"10.1016\/j.semcdb.2016.08.004_bib0455","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/hmg\/ddh285","article-title":"Muscle weakness in a mouse model of nemaline myopathy can be reversed with exercise and reveals a novel myofiber repair mechanism","volume":"13","author":"Joya","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0460","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1083\/jcb.200812132","article-title":"Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin","volume":"185","author":"Nowak","year":"2009","journal-title":"J. Cell Biol."},{"issue":"Pt. 4","key":"10.1016\/j.semcdb.2016.08.004_bib0465","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/brain\/awr004","article-title":"Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies","volume":"134","author":"Ravenscroft","year":"2011","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.semcdb.2016.08.004_bib0470","doi-asserted-by":"crossref","first-page":"e28699","DOI":"10.1371\/journal.pone.0028699","article-title":"Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression","volume":"6","author":"Ravenscroft","year":"2011","journal-title":"PLoS One"},{"issue":"Pt. 6","key":"10.1016\/j.semcdb.2016.08.004_bib0475","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/brain\/awt113","article-title":"Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy","volume":"136","author":"Ottenheijm","year":"2013","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.semcdb.2016.08.004_bib0480","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/hmg\/ddl186","article-title":"Skeletal muscle repair in a mouse model of nemaline myopathy","volume":"15","author":"Sanoudou","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0485","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nmd.2008.09.005","article-title":"Genotype-phenotype correlations in ACTA1 mutations that cause congenital myopathies","volume":"19","author":"Feng","year":"2009","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0490","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/NEN.0b013e318293b1cc","article-title":"Distinct underlying mechanisms of limb and respiratory muscle fiber weaknesses in nemaline myopathy","volume":"72","author":"Lindqvist","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.semcdb.2016.08.004_bib0495","doi-asserted-by":"crossref","first-page":"e45923","DOI":"10.1371\/journal.pone.0045923","article-title":"Nemaline myopathy-related skeletal muscle alpha-actin (ACTA1) mutation, Asp286Gly, prevents proper strong myosin binding and triggers muscle weakness","volume":"7","author":"Ochala","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0500","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2044-5040-1-23","article-title":"Novel mutations in NEB cause abnormal nebulin expression and markedly impaired muscle force generation in severe nemaline myopathy","volume":"1","author":"Lawlor","year":"2011","journal-title":"Skelet. Muscle"},{"issue":"7","key":"10.1016\/j.semcdb.2016.08.004_bib0505","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/humu.22554","article-title":"Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies","volume":"35","author":"Marttila","year":"2014","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.semcdb.2016.08.004_bib0510","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00109-008-0380-9","article-title":"Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction","volume":"86","author":"Ochala","year":"2008","journal-title":"J. Mol. Med."},{"issue":"20","key":"10.1016\/j.semcdb.2016.08.004_bib0515","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1093\/hmg\/dds289","article-title":"Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms","volume":"21","author":"Ochala","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"21","key":"10.1016\/j.semcdb.2016.08.004_bib0520","doi-asserted-by":"crossref","first-page":"9807","DOI":"10.1073\/pnas.1001733107","article-title":"A myopathy-linked tropomyosin mutation severely alters thin filament conformational changes during activation","volume":"107","author":"Ochala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0525","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1096\/fj.10-176727","article-title":"Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy","volume":"25","author":"Ochala","year":"2011","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.semcdb.2016.08.004_bib0530","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddr084","article-title":"Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy","volume":"20","author":"Ottenheijm","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.semcdb.2016.08.004_bib0535","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/hmg\/ddp168","article-title":"Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency","volume":"18","author":"Ottenheijm","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"22","key":"10.1016\/j.semcdb.2016.08.004_bib0540","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1093\/hmg\/ddv334","article-title":"Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres","volume":"24","author":"Yuen","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2016.08.004_bib0545","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-012-1019-z","article-title":"Skeletal muscle alpha-actin diseases (actinopathies): pathology and mechanisms","volume":"125","author":"Nowak","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0550","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/13837","article-title":"Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy","volume":"23","author":"Nowak","year":"1999","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0555","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0883073807309794","article-title":"Dietary l-tyrosine supplementation in nemaline myopathy","volume":"23","author":"Ryan","year":"2008","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0560","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00415-015-8015-x","article-title":"KLHL40-related nemaline myopathy with a sustained, positive response to treatment with acetylcholinesterase inhibitors","volume":"263","author":"Natera-de Benito","year":"2016","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0565","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jmedgenet-2012-101470","article-title":"Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations","volume":"50","author":"de Winter","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcdb.2016.08.004_bib0570","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13395-015-0037-7","article-title":"Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene","volume":"5","author":"de Winter","year":"2015","journal-title":"Skelet. Muscle"},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0575","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2618","article-title":"Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases","volume":"18","author":"Russell","year":"2012","journal-title":"Nat. Med."},{"issue":"6023","key":"10.1016\/j.semcdb.2016.08.004_bib0580","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","article-title":"Cardiac myosin activation: a potential therapeutic approach for systolic heart failure","volume":"331","author":"Malik","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0585","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/156652312800840577","article-title":"Interference with myostatin\/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy","volume":"12","author":"Amthor","year":"2012","journal-title":"Curr. Gene Ther."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0590","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajpath.2010.10.035","article-title":"Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice","volume":"178","author":"Lawlor","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.semcdb.2016.08.004_bib0595","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ana.21035","article-title":"Nemaline myopathy caused by absence of alpha-skeletal muscle actin","volume":"61","author":"Nowak","year":"2007","journal-title":"Ann. Neurol."},{"issue":"19","key":"10.1016\/j.semcdb.2016.08.004_bib0600","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddt252","article-title":"Cardiac alpha-actin over-expression therapy in dominant ACTA1 disease","volume":"22","author":"Ravenscroft","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0605","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.spen.2011.10.008","article-title":"Congenital fiber-type disproportion","volume":"18","author":"Clarke","year":"2011","journal-title":"Semin. Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.semcdb.2016.08.004_bib0610","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ana.21112","article-title":"The pathogenesis of ACTA1-related congenital fiber type disproportion","volume":"61","author":"Clarke","year":"2007","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0615","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.20761","article-title":"SEPN1: associated with congenital fiber-type disproportion and insulin resistance","volume":"59","author":"Clarke","year":"2006","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.semcdb.2016.08.004_bib0620","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.21308","article-title":"Mutations in TPM3 are a common cause of congenital fiber type disproportion","volume":"63","author":"Clarke","year":"2008","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.semcdb.2016.08.004_bib0625","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.20260","article-title":"Actin mutations are one cause of congenital fibre type disproportion","volume":"56","author":"Laing","year":"2004","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.semcdb.2016.08.004_bib0630","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nmd.2010.12.011","article-title":"A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy","volume":"21","author":"Ortolano","year":"2011","journal-title":"Neuromuscul. Disord.: NMD"},{"issue":"25","key":"10.1016\/j.semcdb.2016.08.004_bib0635","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1093\/hmg\/ddt380","article-title":"Congenital myopathy is caused by mutation of HACD1","volume":"22","author":"Muhammad","year":"2013","journal-title":"Hum. Mol. Genet."}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116302427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116302427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:47:07Z","timestamp":1761065227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952116302427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":127,"alternative-id":["S1084952116302427"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.08.004","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future therapeutic approaches to the congenital myopathies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}